dihexa pnb-0408 c-met hgfr activator MET – an ideal target for antibody drug conjugate therapy, plus nivolumab dihexa solution stability data ·
dihexa solution stability data Disguised Alpha Dihexa (PNB 0408) c Met HGFR Activator Dimethyl fumarate Nrf2 Activator MedChemExpress dihexa pnb 0408 Smart Brothers Dihexa PNB 0408 30 caps Pancreatic Cancer Treatment Targeting the HGF c MET Pathway: The MEK Inhibitor Trametinib
Pay in 4 interest-free payments of $7.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



